RBC Capital analyst Gregory Renza maintained a Hold rating on Fulcrum Therapeutics (FULC – Research Report) yesterday and set a price ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...

Fintel reports that on November 13, 2024, RBC Capital initiated coverage of Jumia Technologies AG - Depositary Receipt () (NYSE:JMIA) with a Sector Perform recommendation. Analyst Price Forecast ...

(Nasdaq: IDCC) announced its participation in the upcoming 2024 RBC Capital Markets Technology, Internet, Media & ...

RBC Capital keeps an Outperform rating and $14 price target on Coty after its Q1 like-for-like sale sales growth cut. Unexpected tighter retailer inventory management likely drove downside in the ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

The top 10 underwriters for healthcare issuance accounted for a total of $16.65 billion. RBC Capital Markets ranked No. 1 ...

RBC Capital analyst Deane Dray raised the firm’s price target on Wesco (WCC) to $199 from $186 and keeps a Sector Perform rating on the shares after its Q3 earnings beat. The company’s end ...

RBC Capital raised the firm’s price target on ResMed (RMD) to $232 from $224 and keeps a Sector Perform rating on the shares. The company reported a strong Q1 result with double digit revenue ...

RBC Capital Markets has downgraded Mobileye from Outperform to Sector Perform and slashed its price target from $24 to $11.Market Domination Hosts Julie Hyman and Josh Lipton report more on the ...

TipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including IBM and Ares Capital.

Investing.com - Microsoft's first-quarter results and its current-quarter guidance have left many disappointed investors in ...